Join
Live feed
·
PRReleasevia Quantisnow
Kairos Pharma Ltd. logo

Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics

ByQuantisnow·Wall Street's wire, on your screen.
KAPA· Kairos Pharma Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KAPA (Kairos Pharma Ltd.) and more on Quantisnow.